Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ GeneOne Life Science, Inc.
GeneOne Life Science, Inc.
Industry · 13 registered clinical trials.
Status
Trial
Phase
Started
Unknown
GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery
Sinusitis Chronic
Phase 2
2023-12-01
Unknown
GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)
COVID-19, Healthy
Phase 1
2022-05-23
Unknown
GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19)
Covid19, Healthy
Phase 1
2021-11-01
Completed
GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
Pneumonitis, SARS-CoV Infection
Phase 2
2021-05-07
Completed
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)
SARS-CoV-2
Phase 1 / Phase 2
2020-12-31
Terminated
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
SARS-CoV 2, Infection
Phase 2
2020-06-10
Completed
Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons
HCV Infection
Phase 1
2018-09-04
Completed
Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers
Healthy
Phase 1 / Phase 2
2018-08-28
Completed
GLS-5700 in Dengue Virus Seropositive Adults
Healthy, Zika
Phase 1
2016-08-01
Completed
GLS-5700 in Dengue Virus-Naïve Adults
Healthy
Phase 1
2016-07-01
Completed
Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers
Healthy
Phase 1
2016-02-01
Completed
Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of C
Hepatitis C, Chronic
Phase 1
2014-01-01
Completed
Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males
Healthy
Phase 1
2010-08-01